A chimney stands at the Bayer AG headquarters ahead of a news conference to announce the drugmaker's earnings in Leverkusen, Germany, on Friday, Feb. 28, 2014. Bayer raised its forecast for peak sales of new drugs such as the blood thinner Xarelto even as fourth-quarter results and the revenue outlook for this year missed analyst estimates. Photographer: Jasper Juinen/Bloomberg via Getty Images
Getty Images

Bloomberg Bloomberg